[C1q solid-phase radioimmunoassay for detection of circulating immune complexes in patients with systemic lupus erythematosus (author's transl)]. 1978

M Sato, and R Kasukawa, and S Suzuki, and S Kameda, and T Yoshida

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D003172 Complement C1 The first complement component to act in the activation of CLASSICAL COMPLEMENT PATHWAY. It is a calcium-dependent trimolecular complex made up of three subcomponents: COMPLEMENT C1Q; COMPLEMENT C1R; and COMPLEMENT C1S at 1:2:2 ratios. When the intact C1 binds to at least two antibodies (involving C1q), C1r and C1s are sequentially activated, leading to subsequent steps in the cascade of COMPLEMENT ACTIVATION. C1 Complement,Complement 1,Complement Component 1,C1, Complement,Complement, C1,Component 1, Complement
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000936 Antigen-Antibody Complex The complex formed by the binding of antigen and antibody molecules. The deposition of large antigen-antibody complexes leading to tissue damage causes IMMUNE COMPLEX DISEASES. Immune Complex,Antigen-Antibody Complexes,Immune Complexes,Antigen Antibody Complex,Antigen Antibody Complexes,Complex, Antigen-Antibody,Complex, Immune,Complexes, Antigen-Antibody,Complexes, Immune
D000974 Antibodies, Antinuclear Autoantibodies directed against various nuclear antigens including DNA, RNA, histones, acidic nuclear proteins, or complexes of these molecular elements. Antinuclear antibodies are found in systemic autoimmune diseases including systemic lupus erythematosus, Sjogren's syndrome, scleroderma, polymyositis, and mixed connective tissue disease. Anti-DNA Antibodies,Antibodies, Anti-DNA,Antinuclear Antibodies,Antinuclear Autoantibodies,Antinuclear Autoantibody,Antinuclear Factors,Antinuclear Antibody,Antinuclear Factor,Anti DNA Antibodies,Antibody, Antinuclear,Autoantibody, Antinuclear,Factor, Antinuclear

Related Publications

M Sato, and R Kasukawa, and S Suzuki, and S Kameda, and T Yoshida
May 1988, Journal of clinical & laboratory immunology,
M Sato, and R Kasukawa, and S Suzuki, and S Kameda, and T Yoshida
July 1983, Arthritis and rheumatism,
M Sato, and R Kasukawa, and S Suzuki, and S Kameda, and T Yoshida
March 1987, Clinical immunology and immunopathology,
M Sato, and R Kasukawa, and S Suzuki, and S Kameda, and T Yoshida
October 1988, Gaoxiong yi xue ke xue za zhi = The Kaohsiung journal of medical sciences,
M Sato, and R Kasukawa, and S Suzuki, and S Kameda, and T Yoshida
April 1983, Journal of immunological methods,
M Sato, and R Kasukawa, and S Suzuki, and S Kameda, and T Yoshida
October 1979, Nihon Jinzo Gakkai shi,
M Sato, and R Kasukawa, and S Suzuki, and S Kameda, and T Yoshida
January 1982, Medicina clinica,
M Sato, and R Kasukawa, and S Suzuki, and S Kameda, and T Yoshida
August 1977, Clinical and experimental immunology,
Copied contents to your clipboard!